Perbedaan Diagnos Laboratorium Utama Tbk. dan Griptha Putra Persada Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Griptha Putra Persada Tbk. diperdagangkan di Rp59 (kapitalisasi pasar 60 M, volume 24 jam 661,3 rb). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. jauh lebih besar — sekitar 5,2× kapitalisasi pasar Griptha Putra Persada Tbk., dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 661,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | GRPH | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 60 M |
Volume | 963,6 rb | 661,3 rb |
Lot | 9,64 rb | 6,61 rb |
Perputaran | 217,67 jt | 39,67 jt |
Harga Rata-rata | 225,89 | 59,99 |
Nilai Transaksi | 217,67 jt | 39,67 jt |
Harga Ekuilibrium Indikatif | 226 | 59 |
Volume Ekuilibrium Indikatif | 1 rb | 640 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Selengkapnya di halaman GRPH →